Investor Presentaiton

DNA DNA in brief Business review Q4 and January-December 2018 business review: ☐ ☐ Highlights of the last quarter of 2018 and year 2018 Key operational KPIs and development of subscription base Financial review ☐ Key figures' development Strategy and outlook ☐ DNA's strategic targets and market outlook for 2019 Financial targets and dividend policy Appendices DNA's Investor presentation, February 2019 3

View entire presentation